Adaptive Biotechnologies has appointed Robert Hershberg to its board of directors. Hershberg is CEO, board member, and co-founder of VentiRx Pharamaceuticals, and he previously was senior vice president and chief medical officer at Dendreon, an assistant professor at Harvard Medical School, and an associate physician at Brigham and Women's Hospital.
People in the News: Robert Hershberg
Premium